Cargando…
Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors
Tau hyperphosphorylation is one hallmark of Alzheimer's disease (AD) pathology. Pharmaceutical companies have thus developed kinase inhibitors aiming to reduce tau hyperphosphorylation. One obstacle in screening for tau kinase inhibitors is the low phosphorylation levels of AD-related phospho-e...
Autores principales: | Bretteville, Alexis, Marcouiller, François, Julien, Carl, El Khoury, Noura B., Petry, Franck R., Poitras, Isabelle, Mouginot, Didier, Lévesque, Georges, Hébert, Sébastien S., Planel, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386519/ https://www.ncbi.nlm.nih.gov/pubmed/22761989 http://dx.doi.org/10.1038/srep00480 |
Ejemplares similares
-
Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation
por: Julien, Carl, et al.
Publicado: (2012) -
Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice
por: Papon, Marie-Amélie, et al.
Publicado: (2013) -
Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation
por: Whittington, Robert A., et al.
Publicado: (2013) -
Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer’s disease-like tau pathology
por: Gratuze, Maud, et al.
Publicado: (2017) -
Insulin dysfunction and Tau pathology
por: El Khoury, Noura B., et al.
Publicado: (2014)